(Total Views: 879)
Posted On: 10/11/2020 1:31:30 AM
Post# of 148908
“And then CytoDyn might not have had the money to pursue CV19.”
I doubt this scenario had CYDY started a urothelial cancer in early to mid-2019. Positive results in a urothelial cancer trial (when considering the higher CCR5 concentration), similar to those in the first mTNBC patients, would’ve resulted in a higher SP. That higher SP would’ve permitted CYDY to raise more funds, funds that would’ve eventually been used to pay for COVID19 trials. All hypothetical, of course, but as hypothetical as claiming that starting a urothelial cancer trial would’ve somehow prevented CYDY from starting COVID19 trials. NP knows how to get money and would’ve started those trials even if CYDY were near bankruptcy.
“Best place for armchair QB's is their chair.”
Nah, I prefer to stand so I can get my hips into the throw.
I doubt this scenario had CYDY started a urothelial cancer in early to mid-2019. Positive results in a urothelial cancer trial (when considering the higher CCR5 concentration), similar to those in the first mTNBC patients, would’ve resulted in a higher SP. That higher SP would’ve permitted CYDY to raise more funds, funds that would’ve eventually been used to pay for COVID19 trials. All hypothetical, of course, but as hypothetical as claiming that starting a urothelial cancer trial would’ve somehow prevented CYDY from starting COVID19 trials. NP knows how to get money and would’ve started those trials even if CYDY were near bankruptcy.
“Best place for armchair QB's is their chair.”
Nah, I prefer to stand so I can get my hips into the throw.
(4)
(0)Scroll down for more posts ▼
